AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02495090 — intervention group
Intervention type: GENETIC
Group type: OTHER
Intervention: Exome sequencing
Description: Plain DNA sequencing
Study NCT04756349 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: composite resin restoration
Description: All patients will receive adhesive composite resin restorations. There will be 3 groups (different adhesives): Clearfil SE, Optibond All-in-One and Prime \& Bond Universal.
Study NCT02134041 — intervention group
Intervention type: OTHER
Intervention: traumatic brain injury
Description: mild TBI, GCS >/=13 after traumatic brain injury
Study NCT01431469 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Cow's milk
Description: Powdered Whole Cow's Milk
Study NCT01431469 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Follow-On Formula
Description: Powdered Follow-On Formula with added long-chain Polyunsaturated fatty acid, prebiotics, and polysaccharide
Study NCT01512108 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: liraglutide
Description: 0.9 mg/day liraglutide was injected once daily subcutaneously (s.c., under the skin).
Study NCT01512108 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: oral anti-diabetic drug
Description: An additional oral anti-diabetic drug (OAD) with a different mechanism of action than the pre-trial OAD. The type and dosage of the additional OAD should be chosen by the investigator within the Japanese labelled dose.
Study NCT02402621 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: fentanyl
Description: fentanyl with antiemetic drug
Study NCT02402621 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fentanyl
Description: fentanyl with antiemetic drug
Study NCT00369746 — intervention group
Intervention type: DRUG
Intervention: citalopram
Description: tablets, 60 mg maximum, daily, 12 weeks
Study NCT02224937 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melatonin
Study NCT02224937 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT00805818 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNZ-2566
Description: Solution for intravenous infusion.~20 mg/kg intravenous bolus infusion over 10 minutes followed by a continuous intravenous infusion of 1, 3, or 6 mg/kg/h for a total of 72 consecutive hours.
Study NCT00805818 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sodium Chloride 0.9% Injection
Study NCT02287662 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vancouver 3M Clinical Pathway
Study NCT02278224 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group based rumination focused CBT
Description: The RFCBT is a group trans-diagnostic manual based psychotherapy for depression and anxiety. RFCBT focuses on increasing effective behaviour - i.e., not stopping rumination but making it functional. It's grounded within the core principles and techniques of CBT for depression with two adaptations: (1) a functional-analytical perspective using Behavioural Activation (BA) approaches, (2) an explicit focus on shifting processing style via imagery and experiential approaches.
Study NCT02278224 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Group based CBT
Description: The control group is gold standard group based CBT based on Becks manual for CBT for depression.
Study NCT00772811 — intervention group
Intervention type: DRUG
Group type: NO_INTERVENTION
Intervention: Flu-Mel
Description: * Fludarabine and Melphalan will be infused intravenously over 30 minutes in D5W 100 mL.~* Melphalan will be administered following the completion of Fludarabine infusion at day -2.
Study NCT01039428 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: HS219
Description: Chewing for 30 min three time a day far after meal
Study NCT01039428 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Chewing for 30 min three times a day far after meal
Study NCT00628225 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Counseling and Nicotine replacement (CN)
Description: Professionals in general practice received a central training (4 hours) about smoking, smoking cessation and COPD. They received materials (leaflet, video, smoking cessation protocol and informationfolder). Moreover, professionals received a maximum of 4 practice visits from an outreach visitor. General practitioners were encouraged to advise nicotine replacement.~Smoking COPD patients received smoking cessation counseling and were advised to use nicotine replacement.
Study NCT00628225 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Counseling, Nicotine replacement and Bupropion (CNB)
Description: Professionals in general practice received a central training (4 hours) about smoking, smoking cessation and COPD. They received materials (leaflet, video, smoking cessation protocol and informationfolder). Moreover, professionals received a maximum of 4 practice visits from an outreach visitor. The general practitioner was encouraged to advice the patients to use both nicotine replacements and Bupropion-SR.~Smoking COPD patients received smoking cessation counseling and were advised to use nicotine replacement and Bupropion-SR.
Study NCT01644981 — intervention group
Intervention type: OTHER
Intervention: blood sampling
Description: blood sampling
Study NCT04154995 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Venipuncture
Description: Blood testing at 3, 6 and 12 months
Study NCT04154995 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound Quadriceps Muscles
Description: Ultrasound measurement of quadriceps muscle mass and health
Study NCT00679380 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Blood sampling, endoscopy
Description: Blood sampling for hematology and biochemistry and endoscopy with biopsy for histological and endoscopic assessment scores
Study NCT00679380 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Blood sampling, endoscopy
Description: Blood sampling for hematology and biochemistry and endoscopy with biopsy for histological and endoscopic assessment scores
Study NCT00679380 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Blood sampling, endoscopy
Description: Blood sampling for hematology and biochemistry and endoscopy with biopsy for histological and endoscopic assessment scores
Study NCT00679380 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Budesonide MMX® 6 mg
Description: 6 mg/day, 6 mg tablets
Study NCT00679380 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Budesonide MMX® 9 mg
Description: 9 mg/day, 9 mg tablets
Study NCT00679380 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Entocort EC® 3 mg
Description: 9 mg/day, 3 mg tablets
Study NCT02367183 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Study NCT02786797 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MBSR(BC) 6 Week Program
Description: The MBSR(BC) is a clinical program that provides systematic training to promote stress reduction by self-regulating arousal to stress. The goal of training is to teach participants to become more aware of their thoughts and feelings, and through meditation practice, to have the ability to step back from thoughts and feelings during stressful situations that contribute to increased emotional distress. It incorporates simple yoga, sitting meditation, body scan, and walking meditation in this program. Classes for this intervention occur on a weekly basis for 2 hours for 6 weeks. The participants will be asked to record their informal/formal practices in a daily diary during the program and from 6 weeks to 6 months after the intervention.
Study NCT02786797 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: BCES 6 Week Program
Description: The BCES is an education support program. This 6-week program is based on the published NIH program, Support for People with Cancer: Taking Time Education Support Group. In addition the class sessions consist of group discussion of educational materials and homework assignments; and group processes related to sharing supportive care situations. The participants will record their feelings, coping mechanisms, and questions related to survivorship in a daily diary during the program and from 6 weeks to 6 months after the intervention.
Study NCT02285803 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: transcranial direct current stimulation (tDCS)
Study NCT02285803 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: transcranial direct current stimulation (tDCS)
Study NCT05238402 — intervention group
Intervention type: DRUG
Intervention: Statin
Description: Statin on COVID 19 patienst
Study NCT00289965 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Counselor-administered Brief Motivational Intervention (BMI)
Description: Students participate in a randomized study to evaluate 3 brief interventions: in-person brief motivational intervention, Alcohol 101plus (an interactive CD-ROM program), and AlcoholEdu (a Web-based tutorial). Participants will be followed over 12 months to determine changes in alcohol consumption and related problems.
Study NCT00289965 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Alcohol 101 Plus (interactive CD-ROM)
Description: Students participate in a randomized study to evaluate 3 brief interventions: in-person brief motivational intervention, Alcohol 101plus (an interactive CD-ROM program), and AlcoholEdu (a Web-based tutorial). Participants will be followed over 12 months to determine changes in alcohol consumption and related problems.
Study NCT00289965 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: AlcoholEdu (Internet-based tutorial)
Description: Students participate in a randomized study to evaluate 3 brief interventions: in-person brief motivational intervention, Alcohol 101plus (an interactive CD-ROM program), and AlcoholEdu (a Web-based tutorial). Participants will be followed over 12 months to determine changes in alcohol consumption and related problems.
Study NCT04390178 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 convalescent plasma
Description: Treatment with convalescent plasma (180-200ml) from individuals who have recovered from SARS-CoV-2 infection
Study NCT02268344 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Grass SD9 Stimulator
Description: Electrical stimulation will be applied to the nerve using the Grass SD9 Stimulator at a frequency of 20Hz, 10-15V, for 60 minutes during the surgery. This will occur after the neck dissection has been completed, and the remainder of the surgery will continue during stimulation. The stimulation will be applied using the Grass SD9 Stimulator and the current will be conducted to the nerve using a sterile wire electrode that will be encircled around the nerve at its most proximally-exposed portion (skull base). The wire will be removed after 60 minutes of stimulation has been applied.
Study NCT03910023 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care comporting a home-exercise program (UCHE)
Description: The UCHE intervention will correspond to current practice (including the continuation of previous treatments, if applicable) as decided by the attending physician. The patient will also be provided with a practical guide on how to manage back pain (the back book), including a recommended home exercise program.
Study NCT03910023 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual care comporting a home-exercise program (UCHE)
Description: The UCHE intervention will correspond to current practice (including the continuation of previous treatments, if applicable) as decided by the attending physician. The patient will also be provided with a practical guide on how to manage back pain (the back book), including a recommended home exercise program.
Study NCT03910023 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Spa therapy
Description: the spa-therapy intervention consists of 18 consecutive days of spa-therapy (excepting Sundays), that must occur with 60 days of randomisation. The latter will combine mineral water with physical and hydrotherapeutic treatments, including massages, heat and water exercises.
Study NCT02352402 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Study NCT02352402 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT03761160 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mobile Health App
Description: mobile health app aims to provide patients who are about to initiate androgen deprivation therapy for prostate cancer with an exercise program and better eating habit
Study NCT03761160 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Usual care per hospital guidelines
Study NCT02414984 — intervention group
Intervention type: BIOLOGICAL
Intervention: Golimumab
Description: This is an observational study. Participants with rheumatoid arthritis in Colombia will be observed for 24 months.
Study NCT02221193 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: traditional mouth rinsing and site-specific mouth rinsing (crossover)
Description: blinded prospective, descriptive correlational crossover cross-section clinical trial conduct during the month of Ramadan in the lunar Hajri year 1434 AH (10 July 2013-8 August 2013) in Albaha province in Saudi Arabia involving the application of Listerine® Cool Mint® mouth rinse by either the traditional panoral rinsing method or a site-specific disinfection method targeting the subgingival and supragingival plaque and the posterior third of the tongue dorsum while avoiding the remaining locations within the oral cavity
Study NCT03000140 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High Intensity Interval Training
Description: High Intensity Interval Training pre-hypertensive group; Exercise will be performed at three sessions per week. All sessions will be supervised by an exercise physiologist during 16 weeks.
Study NCT03000140 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: Moderade Intensity Interval Training pre-hypertensive group; Exercise will be performed at three sessions per week. All sessions will be supervised by an exercise physiologist during 16 weeks.
Study NCT02554357 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Exparel block in arthroscopic shoulder surgery
Description: The interscalene block will be performed with ultrasound guidance and nerve stimulation.
Study NCT02554357 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine block in shoulder surgery
Description: The interscalene block will be performed with ultrasound guidance and nerve stimulation.
Study NCT02164760 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Novomaix dermal substitute in combination with STSG
Description: Novomaix dermal substitute in combination with STSG
Study NCT02685085 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Misoprostol ( Prostaglandin E2)
Study NCT02685085 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Foley's catheter
Study NCT01126853 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Twinrix
Description: Up to three intramuscular doses of 1cc of Twinrix (combined hepatitis A/B vaccine) at 0, 1, and 6 months post-enrollment
Study NCT01539538 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sufentanil NanoTab PCA System/15 mcg
Description: 15 mcg Sufentanil NanoTab dosed sublingually q 20 minutes as needed for pain for at least 48 hours and up to 72 hours
Study NCT01539538 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: morphine IV PCA
Description: 1 mg morphine administered IV q 6 minutes as needed for pain for at least 48 hours and up to 72 hours
Study NCT03260309 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Semi-closed loop infusion system tactic.
Description: Semi -closed loop infusion system tactic.Use volume loading test twice (before surgery and 12hrs postoperatively). Computer provides advisory hypotension treatment algorithm. Computer provides advisory anemia treatment algorithm. Programmed iv fluid and blood infusions system ,,Belmont Rapid Infuser and programmable syringe pump for adrenaline infusion.
Study NCT03260309 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Routine infusion therapy tactic
Description: Routine re-hydration bolus before surgery. Routine treatment of hypotension. Routine treatment of anemia.
Study NCT01657669 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Intravitreal Aflibercept injection
Description: Intravitreal Aflibercept injection 2.0 mg dosed every 4 weeks (monthly) for the first 3 months followed by 2.0 mg (0.05mL) via intravitreal injection once every 8 weeks (2 months). Dosing at monthly intervals is allowed if needed in the opinion of the investigator based on presence of fluid on OCT and/or a decrease in visual acuity of 5 letters or more from the best previous visit.
Study NCT05154591 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Adipose-derived stromal vascular fraction cells
Description: Kidney structural and functional changes in 18 patients after 36 months of treatment with SVF cells.
Study NCT03443375 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical exercise
Description: The interventions proposed in the present trial were based on a safe and well-established exercise training program
Study NCT02057679 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amoxicillin clavulanic
Description: 3 g per day divided into 3 oral intakes of 1 g each (2 pill of Amoxicillin Clavulanic every 8 hrs). This treatment will begin on postoperative day 1 for 5 days.
Study NCT02057679 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 1 pill of the same characteristics as Amoxicillin clavulanic every 8 hs. This will begin on postoperative day 1 for 5 days.
Study NCT04105101 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Industrial passive shoulder exoskeleton
Description: Both exoskeleton types are passive shoulder exoskeletons. The goal is to compare the human response to the simulated industrial tasks between the different exoskeleton conditions.
Study NCT01695187 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NB-001 (0.3%)
Description: Topical administration at least five times throughout the day
Study NCT01695187 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT02849678 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine
Description: 0.5% Ropivacaine will be infused through a catheter placed in the thoracic paravertebral space to block the transmission of pain signals at the level of the spinal nerves from the abdominal incision. It is the local anesthetic used as the standard drug in paravertebral nerve blocks at our institution. It is also used in other nerve block infusions at our hospital and institutions across the country. It will be used as the standard drug to which lidocaine is compared.
Study NCT02849678 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine
Description: Lidocaine will be infused through a catheter placed in the thoracic paravertebral space to block the transmission of pain signals at the level of the spinal nerves from the abdominal incision.~At a concentration of 0.5%, Lidocaine has been deemed safe to use for peripheral nerve blocks and analgesia. There are several studies to support this as listed in the references. Compared to ropivacaine, lidocaine is shorter-acting, less cardiotoxic, and safer to use.
Study NCT00679380 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT02459210 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CLUES
Description: Cognition for learning and for understanding everyday social situations intervention described above
Study NCT02459210 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: therapy and computer games
Description: Weekly psychotherapy+ computer games such as sporcle
Study NCT00118404 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Continuation phase cognitive therapy
Description: Continuation phase cognitive therapy included 10 sessions over 8 months.
Study NCT00118404 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Continuation phase fluoxetine
Description: The dosage of fluoxetine was increased to 40 mg over 8 months.
Study NCT00118404 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Continuation phase pill placebo
Description: The dosage of pill placebo was increased to 40 mg over 8 months.
Study NCT00118404 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acute phase cognitive therapy
Description: For the first 12 weeks, all participants received between 16 and 20 cognitive therapy sessions.
Study NCT00118404 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Acute phase cognitive therapy
Description: For the first 12 weeks, all participants received between 16 and 20 cognitive therapy sessions.
Study NCT00118404 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Acute phase cognitive therapy
Description: For the first 12 weeks, all participants received between 16 and 20 cognitive therapy sessions.
Study NCT04540783 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial direct current stimulation (tDCS)
Description: 10 sessions of 2mA and 20 minutes tDCS. Sponges size 5x7 cm. For the sham condition, the patient will receive just 30 seconds of stimulation.
Study NCT04540783 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial direct current stimulation (tDCS)
Description: 10 sessions of 2mA and 20 minutes tDCS. Sponges size 5x7 cm. For the sham condition, the patient will receive just 30 seconds of stimulation.